This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Istituto Nazionale Delle Malattie Infettive “Lazzaro Spallanzani” Irccs. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Enrico Girardi: Innovator in Tuberculosis Diagnostics
Introduction
Enrico Girardi, based in Rome, Italy, is a notable inventor whose contributions to the medical field significantly advance the diagnosis and management of tuberculosis. With one patent to his name, he has made a marked impact on how tuberculosis infections are monitored and diagnosed.
Latest Patents
Girardi's patent titled "Immune Diagnostic Assay to Diagnose and Monitor Tuberculosis Infection" focuses on a groundbreaking method for diagnosing and monitoring various presentations of tuberculosis, including active disease, latent infection, and recent cases. This rapid immune assay evaluates the frequency of interferon (IFN) gamma-producing antigen-specific T lymphocytes that respond to selected peptide sequences known for their immunogenicity. The invention also encompasses immunogenic and vaccine compositions based on these specific peptide sequences, enhancing options for effective tuberculosis management.
Career Highlights
Enrico Girardi is affiliated with the Istituto Nazionale Delle Malattie Infettive “Lazzaro Spallanzani” IRCCS, a prestigious research institution dedicated to infectious diseases. His work there aligns with his innovative endeavors in improving diagnostics and treatment approaches for tuberculosis.
Collaborations
Throughout his career, Girardi has collaborated with esteemed colleagues, including Delia Goletti and Donatella Vincenti. Together, they contribute to the advancement of knowledge and technologies in infectious disease research, bolstering the scientific community's understanding of tuberculosis.
Conclusion
In summary, Enrico Girardi stands out as an inventive force in the fight against tuberculosis. His patented diagnostic methods and collaboration with renowned researchers illustrate his commitment to enhancing healthcare solutions for infectious diseases. Through his innovative spirit, Girardi is paving the way for improved diagnostics and treatments, significantly impacting public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile